121 related articles for article (PubMed ID: 15679791)
1. Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years.
Diefenbach K; Arold G; Wollny A; Schwantes U; Haselmann J; Roots I
BJU Int; 2005 Feb; 95(3):346-9. PubMed ID: 15679791
[TBL] [Abstract][Full Text] [Related]
2. Effect of tolterodine on sleep structure modulated by CYP2D6 genotype.
Diefenbach K; Jaeger K; Wollny A; Penzel T; Fietze I; Roots I
Sleep Med; 2008 Jul; 9(5):579-82. PubMed ID: 17921051
[TBL] [Abstract][Full Text] [Related]
3. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system.
Todorova A; Vonderheid-Guth B; Dimpfel W
J Clin Pharmacol; 2001 Jun; 41(6):636-44. PubMed ID: 11402632
[TBL] [Abstract][Full Text] [Related]
4. Do anticholinergics affect reaction time? A possible impact on the course of rehabilitation.
Karataş GK; Günendi Z
NeuroRehabilitation; 2010; 27(2):141-5. PubMed ID: 20871143
[TBL] [Abstract][Full Text] [Related]
5. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
Malone-Lee J; Shaffu B; Anand C; Powell C
J Urol; 2001 May; 165(5):1452-6. PubMed ID: 11342895
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate.
Chancellor MB; Appell RA; Sathyan G; Gupta SK
Clin Ther; 2001 May; 23(5):753-60. PubMed ID: 11394733
[TBL] [Abstract][Full Text] [Related]
7. Tolterodine: selectivity for the urinary bladder over the eye (as measured by visual accommodation) in healthy volunteers.
Chapple CR; Nilvebrant L
Drugs R D; 2002; 3(2):75-81. PubMed ID: 12001821
[TBL] [Abstract][Full Text] [Related]
8. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
[TBL] [Abstract][Full Text] [Related]
9. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
Kim Y; Yoshimura N; Masuda H; De Miguel F; Chancellor MB
BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654
[TBL] [Abstract][Full Text] [Related]
10. Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.
Chancellor MB; de Miguel F
Geriatrics; 2007 May; 62(5):15-24. PubMed ID: 17489643
[TBL] [Abstract][Full Text] [Related]
11. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
12. Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.
Esin E; Ergen A; Cankurtaran M; Yavuz BB; Halil M; Ulger Z; Yeşil Y; Kuyumcu ME; Ozcan M; Cankurtaran E; Ariogul S
Aging Ment Health; 2015; 19(3):217-23. PubMed ID: 25555041
[TBL] [Abstract][Full Text] [Related]
13. Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers.
Diefenbach K; Donath F; Maurer A; Quispe Bravo S; Wernecke KD; Schwantes U; Haselmann J; Roots I
Clin Drug Investig; 2003; 23(6):395-404. PubMed ID: 17535050
[TBL] [Abstract][Full Text] [Related]
14. Differential pharmacological effects of antimuscarinic drugs on heart rate: a randomized, placebo-controlled, double-blind, crossover study with tolterodine and darifenacin in healthy participants > or = 50 years.
Olshansky B; Ebinger U; Brum J; Egermark M; Viegas A; Rekeda L
J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):241-51. PubMed ID: 18832343
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an experimental urodynamic platform to identify treatment effects: a randomized, placebo-controlled, crossover study in patients with overactive bladder.
Frenkl T; Railkar R; Shore N; Bailen J; Sutherland S; Burke J; Scott BB; Ruddy M; Beals C
Neurourol Urodyn; 2012 Jan; 31(1):69-74. PubMed ID: 21905086
[TBL] [Abstract][Full Text] [Related]
16. The effects of anticholinergic drugs on attention span and short-term memory skills in children.
Giramonti KM; Kogan BA; Halpern LF
Neurourol Urodyn; 2008; 27(4):315-8. PubMed ID: 17828786
[TBL] [Abstract][Full Text] [Related]
17. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
[TBL] [Abstract][Full Text] [Related]
18. Trospium chloride for the treatment of overactive bladder with urge incontinence.
Singh-Franco D; Machado C; Tuteja S; Zapantis A
Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
[TBL] [Abstract][Full Text] [Related]
19. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
20. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
Rahimy M; Hallén B; Narang P
Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
